Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| LMCD1 | Q9NZU5 | LIM and cysteine-rich domains protein 1 (Dyxin) | Predicted intracellular proteins | Metabolism mediationReceptor-signaling mediation | 4 | 0.53 | ||||
| LRCH2 | Q5VUJ6 | Leucine-rich repeat and calponin homology domain-containing protein 2 | Predicted intracellular proteins | Other mediation | 4 | 0.53 | ||||
| MDR3 | P21439 | Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3) | Disease related genesEnzymesHuman disease related genes | 12 | Intrahepatic cholestasisAcute myeloid leukaemiaBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.53 | ||
| MRP2 | Q92887 | ATP-binding cassette sub-family C member 2 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multidrug resistance protein) (Canalicular multispecific organic anion transporter 1) (Multidrug resistance-associated protein 2) | Cancer-related genesDisease related genesEnzymes | 17 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 4 | 0.53 | |||
| NEUFC | Q8WUJ1 | Neuferricin (Cytochrome b5 domain-containing protein 2) | Predicted intracellular proteinsPredicted secreted proteins | Other mediation | 4 | 0.53 | ||||
| PD2R | Q13258 | Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | AsthmaAllergic/hypersensitivity disorderArterial occlusive disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 4 | 0.53 | ||
| SCNNG | P51170 | Epithelial sodium channel subunit gamma (ENaC subunit gamma) (ENaCG) (Epithelial Na(+) channel subunit gamma) (Gamma-ENaC) (Amiloride-sensitive sodium channel subunit gamma) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG) (Sodium channel epithelial 1 subunit gamma) | 2 | Fusion and delivery mediationMetabolism mediation | 4 | 0.53 | ||||
| AA2AR | P29274 | Adenosine receptor A2a | Cancer-related genesFDA approved drug targetsG-protein coupled receptors | 7 | Alzheimer diseaseArterial occlusive diseaseChoreiform disorder | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| AAK1 | Q2M2I8 | AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) | EnzymesPredicted intracellular proteins | General pain disorderCOVID-19Rheumatoid arthritis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | |||
| ABCA1 | O95477 | Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) | Disease related genesEnzymesFDA approved drug targets | 15 | AtherosclerosisCoronary atherosclerosisDyslipidemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.53 |